27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Susquehanna upgraded Chemours Co (NYSE:CC) to Positive from Neutral on reduced litigation risk, improved TiO2 prices and potential upside to 2017 EBITDA outlook.
On Monday, E I Du Pont De Nemours And Co (NYSE:DD) and Chemours announced a global settlement of the multi-district PFOA litigation between DuPont and the plaintiffs. Under the settlement, subject to approval by the plaintiffs, DuPont and Chemours will each pay $335.35 million.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Susquehanna Weighs In
Analyst Don Carson noted that Chemours's portion of the cost is nearly 40 percent lower than Susquehanna’s base-case $550 million estimate.
Related Link: The Sectors Hedge Funds Are Most Bullish And Bearish On To Start 2017
In addition, the average TiO2 pricing in 2016 increased for the first time since 2012. Carson expects $0.05/lb of Chemours's $0.06/lb first quarter price increase to be realized in February due to the unplanned outage at Huntsman's facility in Europe and strong order books.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
“Chemours is well positioned to benefit from the cyclical recovery of TiO2 pricing that is still in early innings as well as faster adoption of Opteon refrigerant due to EU regulatory requirements and voluntary U.S. adoption,” Carson wrote in a note.
Notably, faster Opteon adoption would increase Fluoro products earnings, while Chemours’ margins should benefit from an incremental $150 million of cost savings slated for 2017.
Stock Movement, Now And Ahead
However, despite the earnings beat, shares fell more than 2 percent on Thursday due to 2017 EBITDA guidance of greater than $1 billion that was more modest than investors expected.
But, Carson believes the pullback creates a buying opportunity as he sees significant upside to the EBITDA forecast given greater than expected momentum in TiO2 prices.
In fact, Carson raised his 2017 EBITDA estimate to $1.250 billion and EPS view to $3.00 (prior $960 million and $1.90). The analyst also raised the price target on the shares to $40 from $26.
At last check, shares of Chemours rose 4.23 percent to $33.25.
Image Credit: By Snoopywv - Own work, CC BY-SA 3.0, via Wikimedia Commons27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.